Consolidated income statement
|
5th period (2021) |
4th period (2020) |
3rd period (2019) |
I. Sales | 2,089,632 | 1,198,781 | 1,112,919 |
II. Cost of sales | 1,208,252 | 810,783 | 841,892 |
III. Gross profits | 881,380 | 387,998 | 271,027 |
IV. Selling, General Administrative Expenses | 326,194 | 232,640 | 229,794 |
V. Operating Income | 555,186 | 155,358 | 41,233 |
VI. Other Income | 27,410 | 12,568 | 9,266 |
VII. Other expenses | 44,231 | 27,815 | 38,385 |
VIII. Financial income | 62,589 | 44,135 | 25,985 |
IX. Financial costs | 63,950 | 60,131 | 54,255 |
X. Income from Investments in Associates | 1,619 | 1,757 | 2,042 |
XI. Profit (loss) before income tax from continued operations | 538,622 | 125,872 | -14,114 |
XII. Income tax expense (benefit) from continued operations | 168,012 | 35,924 | 8,882 |
XIII. Income from Continuing Operations | 370,610 | 89,947 | -22,996 |
XIV. Income from discontinued Operations | -101,866 | 165,214 | 28,018 |
XV. Consolidated net income | 268,743 | 255,161 | 5,022 |